Świdnica Public Hospital Awards Multi-Lot Pharmaceutical Supply Contracts to Strengthen Medicine Procurement in Poland
03 Aug 2026
Standfirst Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy has awarded multiple contracts for the supply of pharmaceutical products under a large-scale procurement covering 78 individual lots. Conducted through an open procedure, the procurement secures a two-year supply of medicines required to support hospital operations and patient care. Introduction Hospitals depend on reliable pharmaceutical procurement to maintain uninterrupted patient treatment and ensure the continuous availability of essential medicines across clinical departments. Large healthcare providers increasingly consolidate medicine purchases into multi-lot tenders, allowing suppliers to compete for individual product categories while giving contracting authorities flexibility in supplier selection. In Poland, Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy has completed one such procurement by awarding contracts for pharmaceutical supplies through an open tender procedure. The procurement covers 78 separate packages (lots), enabling suppliers to bid for one, several or all product groups according to their capabilities and product portfolios. Why This Contract Matters Pharmaceutical procurement is among the most critical purchasing activities undertaken by public hospitals. Reliable medicine supply directly supports clinical continuity, patient safety and the efficient operation of healthcare services. By dividing the procurement into multiple lots, the contracting authority encourages wider supplier participation while maintaining flexibility to award contracts individually for different categories of medicines. This procurement model also reduces supply-chain risks by enabling competition across a broad pharmaceutical market. The tender further demonstrates Poland's continued use of transparent public procurement procedures to secure pharmaceutical products that comply with national regulatory and quality requirements while achieving value for public healthcare expenditure. Contract Timeline Milestone Details Procurement Procedure Open Procedure Contract Award Notice Published 3 August 2026 (OJ S 147/2026) Procurement Reference EA/20/PN/2026 Contract Duration 24 months Procurement Structure 78 individual lots (packages) Contract Overview The procurement covers the supply of pharmaceutical products required by Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy. The contracting authority structured the tender into 78 separate packages, allowing bidders to submit offers for one, several or all lots. Partial contract awards were permitted, enabling the hospital to select the most advantageous supplier for each package independently. The technical specification defines product composition, dosage form, route of administration and unit of measurement for each medicine. Equivalent products are permitted where they fully satisfy the hospital's technical and quality requirements. The procurement also allows changes in package sizes where appropriate conversions to full packages can be applied in accordance with the tender documentation. Pharmaceutical products must comply with the requirements of Poland's Pharmaceutical Law and Good Manufacturing Practice regulations. The procurement was conducted under an open procedure in accordance with Directive 2014/24/EU. Contracts are awarded solely on the basis of price (100%). The procurement is not financed by European Union funds and is not covered by the Government Procurement Agreement (GPA). Key Contract Details Item Information Country Poland Contracting Authority Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy Contract Type Supplies Procurement Procedure Open Procedure Main CPV Code 33600000 - Pharmaceutical products Project Supply of Pharmaceutical Products Reference Number EA/20/PN/2026 Number of Lots 78 Contract Duration 24 months Place of Performance Świdnica, Poland Award Criterion Price - 100% EU Funding No Project Scope The procurement has been designed to ensure a stable and uninterrupted supply of pharmaceutical products required for routine hospital operations over a 24-month period. Rather than purchasing medicines through a single contract, the contracting authority divided the procurement into 78 individual lots, enabling suppliers to compete for specific therapeutic categories or product groups according to their expertise and product portfolio. Each lot contains detailed technical specifications covering the required pharmaceutical products, dosage forms, packaging requirements and delivery conditions. The procurement documentation permits suppliers to submit bids for one, multiple or all lots, increasing market participation while allowing the hospital to select the most economically advantageous supplier for each package individually. The contracts cover the delivery of medicines to support the healthcare services provided by the hospital. Suppliers are required to provide products that comply with Polish pharmaceutical regulations and the technical specifications defined in the tender documents. Where permitted, equivalent products may be offered provided they fully satisfy the contracting authority's quality and performance requirements. The award notice indicates that while the majority of packages attracted successful bids, some lots remained unawarded because no tenders were received. This reflects varying levels of supplier participation across different pharmaceutical categories and highlights the challenges associated with sourcing specialised medicines in certain market segments. About the Contracting Authority Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy (SPZOZ Świdnica) is a publicly governed healthcare institution located in Świdnica, Poland. Operating under the public healthcare system, the organisation is responsible for delivering a broad range of medical services and ensuring continuous access to essential medicines for patients across its facilities. The contracting authority's principal activity is healthcare. As the buyer, SPZOZ Świdnica conducted the procurement under the EU public procurement framework through an open procedure to maximise competition and transparency. The hospital also serves as the organisation signing the awarded contracts. About the Organisations Involved Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy SPZOZ Świdnica acted as the contracting authority responsible for planning, managing and awarding the pharmaceutical procurement. The hospital structured the procurement into 78 lots to broaden supplier participation while ensuring long-term medicine availability for patient treatment. SALUS INTERNATIONAL Sp. z o.o. - Winner of LOT-0001 SALUS INTERNATIONAL Sp. z o.o. secured LOT-0001 after submitting the highest-ranked tender. The awarded tender value for this lot amounts to PLN 1,715,155.29. The notice indicates that no subcontracting information was declared for the awarded tender. Additional successful suppliers are identified throughout the award notice for the remaining lots, while several lots were not awarded due to the absence of received tenders. The complete notice reports that the total value of contracts awarded under this procurement is PLN 68,130,764.89. Additional Procurement Facts Country: Poland. Contracting Authority: Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy. Contract Type: Supplies. Procurement Procedure: Open Procedure. Internal Reference Number: EA/20/PN/2026. Main CPV Code: 33600000 – Pharmaceutical products. Procurement divided into 78 individual lots (packages). Total value of contracts awarded in the notice: PLN 68,130,764.89. Contract Duration: 24 months. Partial awards were permitted, allowing suppliers to compete for one, several or all lots. Contracts were awarded to multiple pharmaceutical suppliers across different lots. Some lots remained unawarded because no tenders were received. The evaluation criterion was Price (100%). The procurement is not financed by European Union funds. The procurement is not covered by the Government Procurement Agreement (GPA). Contracts were signed on 24 July 2026 for the awarded lots. Market & Industry Perspective Public hospitals across Europe increasingly procure pharmaceutical products through large multi-lot tenders that encourage competition while reducing supply-chain risk. Rather than relying on a single supplier, contracting authorities distribute awards across multiple manufacturers and distributors, improving resilience in the availability of essential medicines. The Świdnica procurement reflects this approach by dividing medicine requirements into 78 separate packages. This structure enables both multinational pharmaceutical companies and regional distributors to compete for individual product categories while allowing the hospital to select the most competitive offer for each lot. The procurement also highlights the continued importance of transparent, electronic public procurement in Poland's healthcare sector. Multi-supplier awards help hospitals maintain continuity of supply, particularly where different medicines require specialised manufacturers or authorised distributors. Economic Significance With a total awarded value of PLN 68.13 million, the procurement represents a significant investment in pharmaceutical supply for public healthcare. The contracts provide successful suppliers with predictable business over a two-year period while ensuring the hospital can maintain uninterrupted access to essential medicines for patient treatment. Large-scale pharmaceutical procurements such as this play an important role in supporting healthcare delivery, strengthening medicine supply chains and creating long-term commercial opportunities for pharmaceutical manufacturers, wholesalers and authorised distributors. The multi-lot structure also promotes wider market participation by allowing companies to compete in their areas of expertise rather than requiring a single supplier to deliver the entire medicine portfolio. For suppliers, the procurement demonstrates continued demand from Poland's public healthcare sector for reliable pharmaceutical partners capable of meeting regulatory standards, maintaining product availability and ensuring timely delivery throughout the contract period. Future Procurement Opportunities The procurement secures pharmaceutical supplies for a 24-month period, but the hospital's ongoing clinical operations mean demand for medicines will continue beyond the current contracts. While the contract award notice does not specify future procurement schedules, similar multi-lot pharmaceutical tenders are expected as existing agreements approach completion and new medicine requirements emerge. Pharmaceutical manufacturers, authorised distributors and healthcare suppliers should continue monitoring procurement notices issued by Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy and other public healthcare institutions across Poland for future medicine supply contracts, framework agreements and hospital procurement programmes. Opportunities for Suppliers The procurement demonstrates continuing opportunities for companies supplying pharmaceutical products to Poland's public healthcare sector. Suppliers capable of meeting regulatory requirements, maintaining reliable inventories and ensuring timely deliveries are well positioned to compete in future hospital tenders. Pharmaceutical manufacturers. Authorised pharmaceutical wholesalers. Hospital medicine distributors. Suppliers of generic and branded medicines. Specialty pharmaceutical providers. Healthcare logistics and cold-chain distribution companies. Companies offering inventory management and pharmaceutical supply solutions. What Businesses Should Watch Upcoming pharmaceutical procurement notices from public hospitals in Poland. Multi-lot medicine supply tenders issued through open procedures. Framework agreements for long-term pharmaceutical procurement. Hospital demand for specialised and high-value medicines. Public healthcare investments aimed at strengthening medicine supply chains. Opportunities for both domestic and international pharmaceutical suppliers in Poland's healthcare sector. PolandTenders.com Procurement Intelligence This procurement reflects the strategic importance of structured pharmaceutical purchasing in maintaining uninterrupted healthcare delivery. By dividing the tender into 78 individual lots, the hospital increased supplier participation while reducing dependence on a single provider. Such procurement models improve supply resilience and allow contracting authorities to secure competitive pricing across a broad portfolio of medicines. The award also illustrates the continued reliance of public hospitals on transparent, electronic procurement procedures to source essential pharmaceutical products. Multi-supplier awards provide flexibility in supplier selection and help healthcare institutions respond more effectively to changing clinical requirements and market availability. For pharmaceutical companies, the procurement demonstrates that public healthcare remains a stable and significant market. Suppliers with strong regulatory compliance, efficient distribution capabilities and competitive pricing strategies are likely to remain well positioned for future hospital procurement opportunities across Poland. Supplier Takeaways The procurement covers pharmaceutical supplies for a period of 24 months. The tender was divided into 78 individual lots, allowing broad supplier participation. The total value of awarded contracts exceeds PLN 68.13 million. Multiple pharmaceutical suppliers secured contracts across different medicine categories. Price was the sole award criterion, highlighting the importance of competitive pricing. Reliable product availability and regulatory compliance remain key success factors for suppliers serving Poland's public healthcare sector. Key Takeaways Świdnica Public Hospital has completed a major multi-lot pharmaceutical procurement through an open procedure. The contracts ensure long-term availability of essential medicines for hospital operations. The procurement promotes competition by awarding contracts across multiple suppliers and product categories. The total awarded value of more than PLN 68 million highlights the scale of pharmaceutical procurement within Poland's public healthcare system. Multi-lot medicine tenders continue to create significant business opportunities for pharmaceutical manufacturers and distributors. Conclusion The pharmaceutical procurement completed by Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy represents a significant investment in ensuring the continuous availability of medicines for patient care over the next two years. Through a transparent, competitive and multi-lot procurement structure, the hospital has secured a diverse supplier base capable of supporting its clinical requirements across numerous therapeutic categories. Beyond the individual contracts, the procurement highlights the ongoing importance of strategic medicine purchasing within Poland's public healthcare system. As hospitals continue to prioritise reliable supply chains, competitive pricing and regulatory compliance, similar pharmaceutical tenders are expected to remain an important source of opportunities for manufacturers, wholesalers and healthcare distributors. Source: TED European Union, Contract Award Notice, OJ S 147/2026, Notice No. 533477-2026. Published on 3 August 2026. Contracting authority: Samodzielny Publiczny Zespół Opieki Zdrowotnej w Świdnicy
View Details
Poland Awards PLN 13.24 Million Server and Network Infrastructure Contract to Support National e-Grant Platform
31 Jul 2026
Standfirst Poland's Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB) has awarded contracts worth PLN 13.24 million for the supply of server and network infrastructure supporting the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project. The procurement strengthens the country's digital research funding infrastructure through investments in servers, networking equipment and supporting IT systems. Introduction As public institutions continue expanding digital services, investment in reliable IT infrastructure has become essential for supporting modern e-government platforms. The Polish National Information Processing Institute (OPI PIB) has completed a major procurement covering server and network equipment designed to enhance the performance, security and scalability of its digital research funding systems. The procurement, conducted through an accelerated open procedure, was divided into eight lots covering application servers, data-serving servers, network modernisation equipment and related infrastructure. The awarded contracts contribute to the implementation of the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju", a project co-financed through the European Union's Digital Development Programme. Why This Contract Matters Research funding platforms require resilient and high - performance IT infrastructure capable of processing large volumes of applications, research data and digital services. Upgrading server environments and network architecture improves system availability, cybersecurity, operational efficiency and long-term scalability for public sector digital services. The procurement demonstrates Poland's continued investment in digital transformation by strengthening the infrastructure supporting research administration. Modern server platforms, upgraded network equipment and supporting software help public institutions deliver faster, more reliable online services for researchers, universities and innovation stakeholders. The project also highlights the strategic use of European Union funding to modernise public digital infrastructure while supporting long-term digitalisation objectives across government institutions. Contract Timeline Milestone Details Previous Contract Notice 310610-2026 Procurement Procedure Accelerated Open Procedure Winner Selected (Lot A) 12 June 2026 Contract Signed (Lot A) 30 June 2026 Contract Award Notice Published 31 July 2026 (OJ S 146/2026) Contract Overview The procurement covers the supply of server and network infrastructure across multiple lots, including application servers, data-serving servers, network switches, power infrastructure, monitoring equipment and associated software. The equipment will support the implementation and operation of Poland's digital research funding platform while strengthening the technological capabilities of OPI PIB. The procurement was conducted under an accelerated open procedure due to the urgent need to implement infrastructure supporting the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project. The notice confirms that the project is fully or partially financed through European Union funds and includes optional quantities for selected equipment to accommodate future expansion requirements. Key Contract Details Item Information Country Poland Contracting Authority Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB) Contract Type Supplies Procurement Procedure Accelerated Open Procedure Main CPV Code 48820000 - Servers Additional CPV Codes Computer servers, software packages and information systems, data carriers and network equipment Estimated Procurement Value PLN 21,455,053.74 (excluding VAT) Total Awarded Contract Value PLN 13,235,120.00 Project Supply of server and network equipment for the e-Granty digital research funding platform Place of Performance Warsaw, Poland EU Funding Fully or partially financed by European Union funds Project Scope The procurement covers the supply of server and network infrastructure required to strengthen the digital capabilities of the Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB). The overall procurement was divided into eight lots addressing different categories of IT infrastructure, including servers, networking equipment, software and supporting hardware. The contract supports the implementation of the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project, which requires modern, secure and scalable computing infrastructure for the delivery of digital public services related to research funding. According to the contract notice, the project is fully or partially financed through European Union funds. The lots covered by the published award notice include application servers, data serving servers and network modernisation equipment. The procurement also includes optional quantities for selected hardware, allowing the contracting authority to expand infrastructure capacity if operational requirements increase during implementation. Supply of application servers (RACK Type I and Type II). Supply of data-serving servers (RACK Type III). Delivery of network switches for core and data centre environments. Network modernisation equipment for enterprise infrastructure. Environmental monitoring modules. Power Distribution Units (PDUs). Central UPS system with installation. Battery systems and associated supporting equipment. Software and information system components. Infrastructure supporting the national e-Granty digital platform. About the Contracting Authority Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB) is the contracting authority responsible for this procurement. Operating as a public research institute governed by public law, the organisation develops and manages information systems supporting public administration, research and innovation activities in Poland. For this procurement, OPI PIB sought to modernise its IT infrastructure to ensure the successful implementation and operation of digital services supporting research funding administration. The procurement was conducted through an accelerated open procedure to meet project implementation timelines. About the Organisations Involved Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB) acted as the contracting authority and manages the procurement supporting the national digital research funding platform. For Lot A - Application Servers, the contract was awarded to Xcomp Sp. z o.o., Sp. K., whose tender offered the best evaluated price under the procurement criteria. The company will supply the application server infrastructure and related equipment covered by the awarded lot. IT Challenge Sp. z o.o. submitted a competing bid for Lot A but was ranked second during the evaluation process. The Krajowa Izba Odwoławcza (National Appeals Chamber) serves as the review authority responsible for handling procurement appeals associated with the procedure. Procurement Analysis The procurement reflects Poland's continued investment in digital public infrastructure through competitive public procurement supported by European Union funding. The accelerated open procedure was justified by the urgent need to deploy infrastructure required for the timely implementation of the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project. Price was the sole award criterion with a weighting of 100%, demonstrating the contracting authority's emphasis on achieving value for money while procuring infrastructure meeting predefined technical specifications. For Lot A, two electronic tenders were received, providing a competitive evaluation process before the contract was awarded to Xcomp Sp. z o.o., Sp. K.. The procurement is not structured as a framework agreement or dynamic purchasing system. Instead, it represents a direct investment in strategic digital infrastructure intended to enhance the performance, reliability and scalability of public digital services supporting Poland's research and innovation ecosystem. The inclusion of optional hardware quantities also provides flexibility for future infrastructure expansion without requiring an entirely new procurement procedure. Additional Procurement Facts Country: Poland. Contracting Authority: Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB). Contract Type: Supplies. Procurement Procedure: Accelerated Open Procedure. Main CPV Code: 48820000 - Servers. Additional CPV Codes: 48822000 - Computer servers, 48000000 - Software package and information systems, 32582000 - Data carriers, 32420000 - Network equipment and 32428000 - Network upgrade. Estimated Procurement Value: PLN 21,455,053.74 (excluding VAT). Total Value of Contracts Awarded in the Notice: PLN 13,235,120.00. Winning Supplier for Lot A: Xcomp Sp. z o.o., Sp. K.. Winning Tender Value (Lot A): PLN 2,858,720.00. Winner Selected: 12 June 2026. Contract Signed: 30 June 2026. Lot A Estimated Duration: 8 weeks. Price was the sole award criterion with a 100% weighting. Two electronic tenders were received for Lot A. The procurement is fully or partially financed by European Union funds. The procurement is not covered by the Government Procurement Agreement (GPA). No framework agreement or dynamic purchasing system was used. Market & Industry Perspective Public sector organisations across Europe are investing heavily in modern server infrastructure and high-capacity networking equipment to support digital government services, cloud-based applications and secure data processing environments. As government platforms continue to expand, procurement increasingly focuses on scalable computing infrastructure capable of supporting mission-critical public services. This procurement reflects that trend by combining server hardware, network modernisation equipment, software components and power infrastructure within a single technology investment programme. Such integrated procurements help public organisations improve system performance, resilience and cybersecurity while preparing their digital infrastructure for future growth. The inclusion of optional equipment quantities demonstrates a procurement strategy that allows infrastructure expansion without immediately launching additional procurement procedures. This approach offers flexibility while maintaining compatibility across existing technology environments. Economic Significance The procurement represents a significant investment in Poland's digital public infrastructure. With an estimated procurement value exceeding PLN 21.45 million and awarded contracts totalling more than PLN 13.23 million, the project contributes to the modernisation of national research administration systems and supports long-term digital transformation objectives. The investment is linked to the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" programme, strengthening the technological foundation required for the efficient administration of research funding. Reliable server platforms, upgraded networking equipment and supporting infrastructure are expected to improve system availability, operational efficiency and the delivery of digital public services. For technology suppliers, the procurement highlights continuing opportunities within Poland's public sector for enterprise servers, network equipment, software solutions and associated infrastructure services. As public institutions continue modernising their IT environments, demand for advanced digital infrastructure is likely to remain an important segment of the government procurement market. Future Procurement Opportunities The procurement forms part of Poland's ongoing investment in digital public infrastructure supporting research and innovation. While the contract award notice does not specify future procurement schedules, the implementation of the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project indicates continued demand for enterprise IT infrastructure, networking solutions and related digital technologies as public services evolve. The procurement also includes optional quantities for selected hardware components, allowing the contracting authority to expand infrastructure capacity if required during project implementation. Suppliers active in enterprise servers, networking equipment and supporting software should continue monitoring procurement notices issued by Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy (OPI PIB) and other public institutions undertaking digital transformation projects. Opportunities for Suppliers The contract highlights opportunities for technology providers capable of delivering enterprise-grade infrastructure for government digital services. Future procurements associated with public digital transformation programmes are likely to require integrated hardware, software and implementation expertise. Enterprise server manufacturers and distributors. Network infrastructure and switching equipment suppliers. Data centre and IT infrastructure solution providers. Power backup, UPS and energy management equipment suppliers. Software and information system vendors. System integration and infrastructure deployment specialists. IT maintenance and technical support service providers. What Businesses Should Watch Upcoming IT infrastructure procurements issued by OPI PIB. Digital transformation programmes financed through European Union funds. Government investments in research and innovation platforms. Public sector demand for enterprise servers and networking equipment. Future procurements involving data centre modernisation and cybersecurity infrastructure. Technology tenders supporting e-government and digital public services across Poland. PolandTenders.com Procurement Intelligence This procurement demonstrates how governments are strengthening the technological backbone of digital public services through targeted investments in enterprise infrastructure. Rather than acquiring standalone hardware, OPI PIB has adopted an integrated procurement approach covering servers, networking equipment, software and supporting infrastructure required for a large-scale digital platform. The use of an accelerated open procedure reflects the strategic importance of delivering infrastructure within the implementation schedule of the "e-Granty: Platforma Finansowania Nauki Badań i Rozwoju" project. The procurement also illustrates how European Union funding continues to support digital modernisation initiatives that improve the efficiency, accessibility and reliability of public administration. For technology suppliers, the contract reinforces the growing importance of public-sector digital transformation programmes as a stable source of demand for enterprise infrastructure. Vendors capable of providing scalable, secure and high-performance solutions remain well positioned to participate in future government technology procurements. Supplier Takeaways The procurement supports the implementation of Poland's e-Granty digital research funding platform. The total awarded value reported in the notice is PLN 13,235,120.00. Xcomp Sp. z o.o., Sp. K. secured Lot A for application server infrastructure. The procurement was conducted through an accelerated open procedure. European Union funding supports the implementation of the project. Enterprise IT infrastructure continues to represent a significant opportunity within Poland's public procurement market. Key Takeaways Poland continues investing in modern digital infrastructure for public administration. The procurement strengthens technology supporting research funding and innovation services. Competitive tendering ensured value-based supplier selection. Enterprise servers, networking equipment and supporting software remain strategic procurement priorities. EU-funded digital transformation projects continue creating opportunities for technology suppliers. Conclusion The server and network infrastructure procurement awarded by Ośrodek Przetwarzania Informacji - Państwowy Instytut Badawczy represents an important step in strengthening Poland's digital research funding ecosystem. By investing in modern computing and networking infrastructure, the organisation is enhancing the performance, reliability and scalability of services delivered through the national e-Granty platform. Beyond the immediate technology upgrade, the procurement reflects broader public-sector priorities focused on digital transformation, secure information systems and improved online public services. As government institutions continue modernising their IT environments, similar procurements are expected to remain an important component of Poland's public investment strategy. Source: TED European Union, Contract Award Notice, OJ S 146/2026, Notice No. 531987-2026.
View Details
One Bid Per Part: Inside a Gdańsk Hospital Group's PLN 14 Million Implant Tender
30 Jul 2026
Standfirst Copernicus Podmiot Leczniczy, the hospital operator behind three of Gdańsk's largest medical centres, has awarded 18 parts of a 49 part tender for hip, knee and shoulder implants and other medical devices to four global orthopaedics suppliers, worth a combined PLN 14 068 675. Every single awarded part drew exactly one bid, a competition pattern worth watching closely as 31 parts of the original tender remain unresolved. Introduction A hip replacement or a knee reconstruction depends on a supply chain most patients never think about: the implant itself has to be ordered, matched to the patient and delivered to the operating theatre, often within days. Hospitals secure that supply through public tenders that can run to dozens of separate parts, one for each type of device, each evaluated and awarded on its own terms. Copernicus Podmiot Leczniczy Sp. z o.o., the company that runs Gdańsk's Copernicus Hospital, St. Adalbert's Hospital and the regional oncology centre, split its latest device tender into 49 such parts. This result notice covers 18 of them, worth PLN 14 068 675 combined, split among four established orthopaedic and medical device suppliers. What stands out is not the winners themselves but how they won: every one of the 18 awarded parts received exactly one tender. Why This Contract Matters Hospitals rely on implant supply chains that most patients never see and a Gdańsk based operator managing multiple hospital sites, including a dedicated oncology centre, depends on reliable access to hip, knee and shoulder implants alongside devices used in breast surgery. This tender keeps that pipeline running for the affected product categories. The single bid pattern across every awarded part is the real story here. In a market served by several large global manufacturers, competing bids on every part would be the expected outcome. A run of uncontested awards across 18 separate parts suggests either that individual parts were specified narrowly enough that only one supplier's product qualified or that competing manufacturers chose not to bid on parts they judged were effectively pre matched to a specific brand. The notice itself does not explain why competition was so limited. The tender documents also apply the European Union's new International Procurement Instrument measure against Chinese medical devices, a genuinely significant trade policy development that reaches into routine hospital procurement across the bloc. Contract Timeline Original 49 part tender notice referenced by this result: 432524 2026 Winner selected for all 18 awarded parts: 20 July 2026 Contracts concluded for most parts: 22 July 2026 Contracts concluded for the Smith and Nephew and Arthrex awards: 23 July 2026 Notice dispatched to the Publications Office: 29 July 2026 Published in the Official Journal, OJ S 145/2026: 30 July 2026 Contract Overview Copernicus Podmiot Leczniczy ran an open procedure under Directive 2014/24/EU for the supply of hip and knee arthroplasty endoprostheses, shoulder prostheses, devices used in breast surgery procedures and various other medical devices, split into 49 parts. This result notice reports outcomes for 18 of those parts. The contracting authority has not disclosed the status of the remaining 31 parts within this notice. Four suppliers won the 18 disclosed parts. Zimmer Biomet Polska Sp. z o.o. won 9 parts worth a combined PLN 6 989 185. Enovis Poland Sp. z o.o. won 6 parts worth PLN 4 817 490. Smith and Nephew Sp. z o.o. won 2 parts worth PLN 1 788 600. Arthrex Polska Sp. z o.o. won 1 part worth PLN 473 400. Every one of the 18 parts received exactly one tender. Key Contract Details Contracting authorityCopernicus Podmiot Leczniczy Sp. z o.o. Contract titleSupply of endoprostheses for hip and knee arthroplasty, shoulder prostheses, breast surgery devices and various medical devices CPV code33183100 orthopaedic implants, plus 33184100, Surgical implants Procedure typeOpen procedure Legal basisDirective 2014/24/EU Total parts in original tender49 Parts covered in this result notice18 Value of all contracts awarded in this noticePLN 14 068 675, excluding VAT Contract duration per part24 months Award criteriaPrice 98 percent, delivery lead time 2 percent Tenders received per awarded part1, in every case WinnersZimmer Biomet Polska, Enovis Poland, Smith and Nephew, Arthrex Polska Winner selected20 July 2026, all parts GPA coverageNo, all parts EU fundingNo, all parts Framework structureNo framework agreement, direct supply contracts Review bodyKrajowa Izba Odwoławcza (National Appeals Chamber) Notice reference528371 2026, OJ S 145/2026, published 30 July 2026 Project Scope The overall tender covers hip and knee arthroplasty endoprostheses, shoulder prostheses, devices used in breast surgery and a range of other medical devices for use across Copernicus Podmiot Leczniczy's hospital sites in Gdańsk. The notice does not break down which specific implant type each individual part covers. Detailed product requirements and estimated quantities sit in the tender's annexes rather than in the published notice itself. The underlying tender documentation offers contracting parties a choice of five contract models: a straightforward sale, a sale bundled with loaned surgical instrumentation and three consignment style arrangements, described as commission contracts without loaned instruments over either 24 or 18 months and a commission contract with loaned instruments. The notice does not specify which of these models applies to which of the 18 awarded parts. Delivery for each part is required within a maximum of 5 working days of an order, with faster delivery scored favourably in the award criteria. Notably, the tender conditions apply the European Union's International Procurement Instrument measure against China, requiring winning suppliers to source no more than 50 percent of contract value from operators or products originating in China and imposing a proportional penalty of 30 percent of contract value for non compliance. About the Contracting Authority Copernicus Podmiot Leczniczy Sp. z o.o. is a body governed by public law active in the health sector, based in Gdańsk. It is classified in the notice as a body governed by public law with an activity of health. Independent Polish company records confirm the entity's registration number matches this notice and describe it as a company whose main activity is hospital operations, based at ul. Nowe Ogrody 1 6 in Gdańsk. Public information from the company's own hospital network shows it manages the Nicolaus Copernicus Hospital, St. Adalbert's Hospital and the Provincial Oncology Centre among its facilities in Gdańsk. The Pomorskie Voivodeship is listed in Polish corporate registry data as the company's shareholder, reflecting its status as a regional public healthcare operator rather than a single standalone hospital. About the Organisations Involved Copernicus Podmiot Leczniczy Sp. z o.o. As covered above, Copernicus Podmiot Leczniczy is the buyer behind this tender, running the process through its Public Procurement Department, with contact handled through zamowienia.publiczne@copernicus.gda.pl. Krajowa Izba Odwoławcza Krajowa Izba Odwoławcza, the National Appeals Chamber, based in Warsaw, is named as the review organisation and the body providing further information on review procedures for every part of this tender. It is Poland's central public procurement dispute body, operating under the Polish Public Procurement Office. Review deadlines for this tender are governed by Article 515 of Poland's Public Procurement Law, according to the notice. Zimmer Biomet Polska Sp. z o.o. Zimmer Biomet Polska is the largest winner in this result, classified as a large enterprise and based in Warsaw. It won 9 parts, spanning 11 separate contract records since two parts, Part 4 and Part 14, were each split into two separate contracts awarded to the company. Its combined winning value across these parts is PLN 6 989 185, ranging from a single contract worth PLN 18 100 up to one worth PLN 2 275 800. Zimmer Biomet is part of a global joint replacement and orthopaedics group with an established presence in the Polish hospital device market. Enovis Poland Sp. z o.o. Enovis Poland, classified as a small enterprise and based in Warsaw, won 6 parts worth a combined PLN 4 817 490, the second largest share of this award both by value and by number of parts won. Its winning tenders ranged from PLN 202 000 up to PLN 1 522 350. Enovis operates globally in orthopaedic devices and surgical recovery products. Smith and Nephew Sp. z o.o. Smith and Nephew, classified as a large enterprise and based in Warsaw, won 2 parts across 3 separate contract records, since Part 15 was split into two contracts. Its combined winning value is PLN 1 788 600. Smith and Nephew is a globally established medical device manufacturer with a long standing presence in orthopaedic and surgical device supply. Arthrex Polska Sp. z o.o. Arthrex Polska, classified as a medium enterprise and based in Warsaw, won a single part, Part 19, worth PLN 473 400. Arthrex is known internationally for minimally invasive orthopaedic surgical devices. Procurement Analysis The tender ran as an open procedure under the general EU public sector directive, evaluated almost entirely on price. Price carried 98 percent of the score, calculated by dividing the lowest submitted price by each tender's price and multiplying by the weight, while a delivery lead time criterion carried the remaining 2 percent, scored on a simple tiered scale rewarding faster delivery commitments. With price this dominant, the outcome of each part was effectively decided by whichever single supplier chose to bid. The most significant procurement signal in this notice is that every one of the 18 disclosed parts received exactly one tender. None of the statistical breakdowns for tenders from other EU or non-EU countries recorded any bids beyond the single domestic tenderer per part. For a category of device supplied globally by multiple competing manufacturers, that level of single bidding across an entire batch of parts points toward narrow, product specific technical specifications, a pattern common in medical device tenders where clinical teams request equipment matched to instrumentation or techniques already in use at the hospital, even where the buyer formally permits equivalent alternative products, as this notice does. None of the 18 awarded parts are covered by the Government Procurement Agreement, none are financed with EU funds and none carry a framework structure, meaning each is a direct, standalone supply contract for its 24 month term rather than part of an ongoing panel arrangement. The contracting authority has not disclosed the number of complaints received in connection with this tender. Additional Procurement Facts This result notice covers only 18 of the 49 total parts that made up the original tender. The contracting authority has not disclosed the outcome of the remaining 31 parts in this notice. Two of the 18 awarded parts, Part 4 and Part 14, each appear twice in the results with separate contract values, both awarded to Zimmer Biomet Polska. The notice does not explain why these parts generated two distinct contract records rather than one. The contracting authority has not disclosed an original estimated value for the tender at either procedure or part level, so no comparison between estimate and awarded value is possible. Subcontracting is marked as not applicable across the awarded parts and none of the winning tenders are recorded as variant bids. The tender's exclusion conditions explicitly reference EU sanctions measures related to Russia's actions in Ukraine alongside the EU's International Procurement Instrument measure against China, both cited as grounds for excluding certain tenderers from participation. Market and Industry Perspective Orthopaedic implant procurement in European hospitals typically draws bids from a recognisable group of global manufacturers, the same four companies that appear as winners here among them. A tender where every part attracts only one bid suggests that, for this particular batch of parts, the field effectively narrowed to a single qualified supplier before bidding even opened, whether through specification design, existing hospital equipment compatibility or supplier decisions not to compete on parts outside their core product lines. This tender also lands inside a genuinely significant piece of EU trade policy. The bloc's International Procurement Instrument measure against Chinese medical devices, adopted in June 2025 following a Commission investigation, marked the Commission's first use of the instrument to exclude Chinese medical device suppliers from EU public contracts worth more than 5 million euro for five years, effective from the end of June 2025. The measure followed findings that discriminatory requirements applied in the large majority of medical device procurement procedures conducted in China and it now requires contracting authorities across the EU, including this Gdańsk hospital operator, to write Chinese sourcing limits directly into their tender conditions even on contracts far smaller than the measure's own 5 million euro threshold. Economic Significance At PLN 14 068 675 across 18 parts, this is a modest tender by national healthcare spending standards, but it represents only just over a third of the original 49 part procurement by count, with the value of the remaining 31 parts undisclosed. The full tender, once all parts are resolved, is likely to represent a considerably larger commitment for a regional hospital group already managing multiple sites including a dedicated oncology centre. Future Procurement Opportunities The most immediate opportunity sits with the 31 parts of the original 49 part tender not covered by this notice. Whether those parts failed to attract any bids, remain under evaluation or will be reported in a separate result notice is not disclosed here, but their resolution is the natural next step for anyone tracking this procurement. Beyond that, each of the 18 awarded parts carries a 24 month term with no framework or renewal structure attached, meaning Copernicus Podmiot Leczniczy will need to return to the market for each product category once the current term ends, offering a predictable recompete window roughly two years out. Opportunities for Suppliers The single bid outcome across all 18 parts is the clearest signal for orthopaedic and medical device suppliers considering this buyer. Manufacturers who did not participate this time have an opening to review the specifications behind the unresolved 31 parts and any future recompete, particularly where equivalent alternative products are explicitly permitted under Polish procurement law, as stated in this notice. Because price carries 98 percent of the score, suppliers positioning for future parts of this tender or its eventual recompete, should treat cost competitiveness as the dominant factor, with only a small, clearly defined delivery speed criterion available to differentiate beyond price. What Businesses Should Watch Whether Copernicus Podmiot Leczniczy publishes a further result notice covering the 31 parts not disclosed here. Whether the pattern of single bid awards persists if and when those remaining parts are resolved. How the EU's International Procurement Instrument measure against Chinese medical devices continues to shape tender conditions across other EU hospital procurements as its five year term progresses. The timing of any recompete as the 24 month contract terms on these 18 parts approach expiry. PolandTenders.com Procurement Intelligence This notice is a useful reminder that a competitive procurement framework does not automatically produce a competitive result. Every one of the 18 parts disclosed here was awarded after exactly one bid, despite an open procedure available in principle to any qualified EU supplier and despite a market with several credible manufacturers, four of whom did in fact win business here, just never against each other on the same part. The strategic lesson for suppliers is that in fragmented, multi part medical device tenders like this one, winning is often decided long before submission, through how closely a hospital's specification matches a supplier's existing product and instrumentation footprint at that facility. Manufacturers hoping to break into a buyer's supply base should treat the specification stage, not the bid stage, as the point of real competition and should engage with equivalence provisions early rather than waiting for tender publication. The presence of the EU's China focused International Procurement Instrument language in a tender of this modest size also signals how quickly major trade policy measures filter down into routine institutional purchasing. Suppliers operating supply chains that touch Chinese sourced components, even indirectly, should expect this kind of clause to become a standard feature of EU medical device tenders for the coming years, regardless of individual contract size. Supplier Takeaways Every one of the 18 awarded parts in this tender received exactly one bid, a competition level suppliers should note carefully before assuming this market is broadly contestable. Award criteria were dominated by price, at 98 percent, with only a small delivery speed criterion available for differentiation. Zimmer Biomet Polska secured the largest share, 9 parts worth PLN 6 989 185, followed by Enovis Poland with 6 parts worth PLN 4 817 490. This tender applies the EU's International Procurement Instrument measure against Chinese medical devices, capping Chinese sourced content at 50 percent of contract value with a 30 percent penalty for breach. 31 of the original 49 tender parts remain undisclosed in this notice, representing a meaningful pending opportunity. Key Takeaways Copernicus Podmiot Leczniczy awarded 18 of 49 parts in its orthopaedic implant and medical device tender, worth a combined PLN 14 068 675. Four suppliers won business: Zimmer Biomet Polska, Enovis Poland, Smith and Nephew and Arthrex Polska. Every awarded part received exactly one tender, an unusually low competition level for a global medical device category. Award criteria weighted price at 98 percent and delivery speed at 2 percent. The tender applies the EU's new International Procurement Instrument measure restricting Chinese medical device access to EU public contracts. 31 parts of the original 49 part tender are not covered by this result notice. Conclusion Behind the routine language of a hospital device tender sits a pointed procurement story: eighteen separate contract decisions, each made with only one bid on the table, for equipment that keeps orthopaedic and oncology care running across one of Poland's larger regional hospital groups. With 31 parts of the original tender still unaccounted for and a major EU trade measure now written into the fine print, this is a procurement worth revisiting once the fuller picture emerges. Source: TED Contract Award Notice 528371-2026, Official Journal of the European Union, OJ S 145/2026, published on 30 July 2026. Contracting Authority: Copernicus Podmiot Leczniczy Sp. z o.o.
View Details